Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin

Saved in:
Bibliographic Details
Published inThe Israel Medical Association journal Vol. 11; no. 3; p. 188
Main Authors Shapiro, Maurice, Cohen, Johnathan, Inbal, Aida, Singer, Pierre
Format Journal Article
LanguageEnglish
Published Israel 01.03.2009
Subjects
Anticoagulants - immunology
Anticoagulants - pharmacology
Antithrombins - therapeutic use
Chondroitin Sulfates - immunology
Chondroitin Sulfates - pharmacology
Cross Reactions - drug effects
Cross Reactions - immunology
Dermatan Sulfate - immunology
Dermatan Sulfate - pharmacology
Heparinoids - adverse effects
Heparinoids - immunology
Heparitin Sulfate - immunology
Heparitin Sulfate - pharmacology
Hirudins
Humans
Male
Middle Aged
Peptide Fragments - therapeutic use
Platelet Aggregation - drug effects
Recombinant Proteins - therapeutic use
Thrombocytopenia - chemically induced
Online AccessGet full text

Cover

More Information
ISSN:1565-1088